Nishigaichi A, Amano Y, Minoda Sada R, Miyake H, Maruyama W, Tagawa S
J Gen Intern Med. 2024; 40(2):479-484.
PMID: 39249649
PMC: 11803066.
DOI: 10.1007/s11606-024-09012-1.
Kampoli K, Tsamis I, Sgouros D, Katsimbri P, Koumarianou A
Immunotherapy. 2024; 16(11):709-714.
PMID: 38888430
PMC: 11421299.
DOI: 10.1080/1750743X.2024.2362107.
Oeztuerk M, Henes A, Schroeter C, Nelke C, Quint P, Theissen L
Cells. 2023; 12(20).
PMID: 37887300
PMC: 10605022.
DOI: 10.3390/cells12202456.
Shimoda M, Tanaka Y, Taniguchi A, Morimoto K, Yoshimori K, Ohta K
Int Cancer Conf J. 2023; 12(3):173-176.
PMID: 37251005
PMC: 10212843.
DOI: 10.1007/s13691-023-00601-1.
Wu Z, Xu H, Zhang S
Front Immunol. 2022; 13:857030.
PMID: 35371082
PMC: 8967955.
DOI: 10.3389/fimmu.2022.857030.
The Significance of Autoantibodies in Juvenile Dermatomyositis.
Kwiatkowska D, Reich A
Biomed Res Int. 2021; 2021:5513544.
PMID: 34840975
PMC: 8626176.
DOI: 10.1155/2021/5513544.
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies.
Misra A, Wong N, Healey T, Lally E, Shea B
BMC Pulm Med. 2021; 21(1):370.
PMID: 34775966
PMC: 8591876.
DOI: 10.1186/s12890-021-01737-7.
Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
Chung S, Yoo I, Kim J, Kang S, Kwon M, Joung C
Yonsei Med J. 2021; 62(5):424-430.
PMID: 33908213
PMC: 8084694.
DOI: 10.3349/ymj.2021.62.5.424.
Clinical utility of ANA-ELISA vs ANA-immunofluorescence in connective tissue diseases.
Alsaed O, Alamlih L, Al-Radideh O, Chandra P, Alemadi S, Al-Allaf A
Sci Rep. 2021; 11(1):8229.
PMID: 33859213
PMC: 8050204.
DOI: 10.1038/s41598-021-87366-w.
Real world utilization of the myositis autoantibody panel.
Maheswaranathan M, Johannemann A, Weiner J, Jessee R, Eudy A, Criscione-Schreiber L
Clin Rheumatol. 2021; 40(8):3195-3205.
PMID: 33629202
DOI: 10.1007/s10067-021-05658-y.
Papillitis with retinal venous congestion and intraocular inflammation.
Wu C, Dunn J, Sergott R
Am J Ophthalmol Case Rep. 2020; 20:100913.
PMID: 32984653
PMC: 7495011.
DOI: 10.1016/j.ajoc.2020.100913.
Classical Dermatomyositis: A Case Report.
Pokhrel S, Pardhe B, Giri N, Pokhrel R, Paudel D
Clin Cosmet Investig Dermatol. 2020; 13:123-126.
PMID: 32104038
PMC: 7008393.
DOI: 10.2147/CCID.S234452.
Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.
Wu J, Lu M, Reed A
World J Pediatr. 2019; 16(1):31-43.
PMID: 31556011
DOI: 10.1007/s12519-019-00313-8.
Diagnostic Imaging of Inflammatory Myopathies: New Concepts and a Radiological Approach.
Brandao Guimaraes J, Nico M, Omond A, Aivazoglou L, Jorge R, Zanoteli E
Curr Rheumatol Rep. 2019; 21(3):8.
PMID: 30762122
DOI: 10.1007/s11926-019-0807-z.
Coexistence of anti-HMGCR and anti-MDA5 identified by an unlabeled immunoprecipitation assay in a chinese patient cohort with myositis.
Huang L, Wang L, Yang Y, Chen H, Liu Y, Liu K
Medicine (Baltimore). 2018; 97(47):e13236.
PMID: 30461626
PMC: 6392932.
DOI: 10.1097/MD.0000000000013236.
Classification and management of adult inflammatory myopathies.
Selva-OCallaghan A, Pinal-Fernandez I, Trallero-Araguas E, Milisenda J, Grau-Junyent J, Mammen A
Lancet Neurol. 2018; 17(9):816-828.
PMID: 30129477
PMC: 11646336.
DOI: 10.1016/S1474-4422(18)30254-0.
Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay.
Wang L, Huang L, Yang Y, Chen H, Liu Y, Liu K
Clin Rheumatol. 2018; 37(10):2731-2739.
PMID: 30039266
DOI: 10.1007/s10067-018-4216-x.
Bench to bedside review of myositis autoantibodies.
Palterer B, Vitiello G, Carraresi A, Giudizi M, Cammelli D, Parronchi P
Clin Mol Allergy. 2018; 16:5.
PMID: 29540998
PMC: 5840827.
DOI: 10.1186/s12948-018-0084-9.
The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders.
Gofrit S, Yonath H, Lidar M, Shoenfeld Y, Kivity S
Clin Rheumatol. 2018; 37(5):1257-1263.
PMID: 29453582
DOI: 10.1007/s10067-018-4032-3.
Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer.
Aussy A, Boyer O, Cordel N
Front Immunol. 2017; 8:992.
PMID: 28871260
PMC: 5566616.
DOI: 10.3389/fimmu.2017.00992.
